- Product Theaters will take place in the Exhibit Hall (Halls 2-3) at the Henry B. Gonzalez Convention Center
Two Exciting Breast Cancer Educational Opportunities in San Antonio
San Antonio Marriott Rivercenter, Salon E
These CME symposia are sponsored by Clinical Care Options, LLC. “Experts Debate and Discuss Therapeutic Strategies Using CDK4/6 Inhibitors Across Breast Cancer” is supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation. “Estrogen Receptor Mutations in HR+ Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions” is supported by educational grants from AstraZeneca and Lilly.
Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer (Part 1 of a 3-Part CME Symposium Series)
San Antonio Marriott Rivercenter, Grand Ballroom G-M
This CME symposium is sponsored by Research To Practice, and supported by educational grants from AstraZeneca Pharmaceuticals LP and Daiichi Sankyo Inc.
The Amazing Case: Hormone Receptor Positive/HER2-Negative Breast Cancer Edition
San Antonio Marriott Rivercenter, Salon B/F
This CME symposium is sponsored by Medscape and supported by educational grants from Genentech.
Reducing the Risk of Recurrence in HR+/HER2- Early Breast Cancer
Exhibit Hall, Product Theater A
Presented by Novartis
MasterClass mBC. Actionable Mutations in 2nd Line: ESR1 and Informed Decision Making
Exhibit Hall, Product Theater B
Presented by Menarini Stemline
Explore the Current Data That Could Help You Recognize/Assess Candidates for a CDK4 & 6 Inhibitor
Exhibit Hall, Product Theater A
Presented by Lilly
Pfizer and Flatiron Health: The Importance of a Holistic Approach to Advancing Breast Cancer Research
Exhibit Hall, Product Theater B
Presented by Flatiron Health
How Can Genomic Information from a Single Core Biopsy Sample Inform Multiple Therapy Decisions for Early Stage ER+ Breast Cancer?
Exhibit Hall, Product Theater A
Presented by Agendia, Inc.
Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer (Part 2 of a 3-Part CME Symposium Series)
San Antonio Marriott Rivercenter, Grand Ballroom G-M
This CME symposium is sponsored by Research To Practice, and supported by educational grants from AstraZeneca Pharmaceuticals LP, Lilly, Novartis, and Stemline Therapeutics Inc.
Moving the Needle in ER+/HER2- Metastatic Breast Cancer: Exploring SERD Strategies to Optimize Outcome
San Antonio Marriott Rivercenter, Salon B/F
This CME symposium is sponsored by Medscape Oncology and supported by educational grants from Lilly.
Treatment Considerations for Specific Populations With HR+/HER2- mBC: Endocrine Sensitivity or ≥65 Years
Exhibit Hall, Product Theater A
Presented by Pfizer Oncology
Come Learn More About Lynparza
Exhibit Hall, Product Theater B
Presented by AstraZeneca
Gilead and Kite Oncology’s Commitment to Transformative Sciences
Exhibit Hall, Product Theater A
Presented by Gilead Sciences
Come see the latest clinical evidence for ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Exhibit Hall, Product Theater A
Presented by Daiichi Sankyo, Inc. and AstraZeneca
Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer (Part 3 of a 3-Part CME Symposium Series)
San Antonio Marriott Rivercenter, Grand Ballroom G-M
This CME symposium is sponsored by Research To Practice and supported by educational grants from AstraZeneca Pharmaceuticals LP and Daiichi Sankyo Inc.
HER2+ Metastatic Breast Cancer: Current Clinical Insights
Exhibit Hall, Product Theater A
Presented by Pfizer Oncology
Comprehensive Genomic Profiling (CGP) in HR+/HER2- Advanced Breast Cancer. Learn How CGP Testing Can Identify Personalized Therapy Options for Your Patients
Exhibit Hall, Product Theater A
Presented by Foundation Medicine